Picture Berlin Partner Top News Captain T Cell Therapies 650x100px

News > All

Total search results: 3657 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 8 9 10 ... 35 36 37  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge. 2022-12-19
Eckert & Ziegler Strahlen- und Medizintechnik AG. (12/19/22). "Press Release: Changes in the Management Board of Eckert & Ziegler. Insider Information Pursuant to Article 17 MAR". Cambridge. 2022-12-19
ADC Therapeutics S.A.. (12/19/22). "Press Release: ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer". Lausanne. 2022-12-19
Nykode Therapeutics A/S. (12/19/22). "Press Release: Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership". Oslo. 2022-12-19
CRISPR Therapeutics AG. (12/19/22). "Press Release: CRISPR Therapeutics Announces the Appointment of Alex Harding, M.D., M.B.A., as Head of Business Development". Zug & Boston, MA. 2022-12-19
Boehringer Ingelheim. (12/19/22). "Press Release: Boehringer Ingelheim and Click Therapeutics Expand Their Existing Collaboration to Develop Prescription Digital Therapeutics for Schizophrenia". Ingelheim & New York, NY. 2022-12-19
Polyplus-transfection S.A.. (12/17/22). "Press Release: Polyplus Acquires Xpress Biologics to Expand Plasmid DNA Offer". Strasbourg. 2022-12-17
BioSpring GmbH. (12/16/22). "Press Release: BioSpring Expands in Offenbach – up to 1,500 New Jobs". Offenbach am Main. 2022-12-16
Beiersdorf AG. (12/16/22). "Press Release: Beiersdorf Acquires S-Biomedic and Strengthens Expertise in the Field of Acne Treatment". Hamburg. 2022-12-16
T-Curx GmbH. (12/15/22). "Press Release: T-Curx GmbH Announces the Appointment of Thomas (Tom) Loeser as CFO and the Attendance at the JPM 41st Annual Healthcare Conference 2023 in San Francisco". Würzburg. 2022-12-15
Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. 2022-12-15
Storm Therapeutics Ltd.. (12/14/22). "Press Release: Storm Therapeutics Announces Closing of USD $30M Series B Financing". Cambridge. 2022-12-14
Lipotype GmbH. (12/13/22). "Press Release: Lipotype, a Leading Lipidomics Service Provider, Launches US Subsidiary in Cambridge, Massachusetts". Cambridge, MA & Dresden. 2022-12-13
Amgen Inc.. (12/13/22). "Press Release: Blincyto (blinatumomab) Added to Consolidation Chemotherapy Significantly Improves Survival in Adult Patients with Measurable Residual Disease-negative B-Lieage Acute Lymphoblastic Leukemia (B-ALL)". Thousand Oaks, 2022-12-13
Merck KGaA. (12/13/22). "Press Release: Merck Signs MoU with Synplogen to Accelerate Development and Manufacturing of Viral Vector-based Gene Therapy Applications". Tokyo. 2022-12-13
BioM Biotech Cluster Development GmbH. (12/12/22). "Press Release: Martinsried Gets Start-up Incubator Munich Accelerator Life Sciences & Medicine (MAxL)". Martinsried. 2022-12-12
TGZ Halle Technologie- und Gründerzentrum Halle GmbH. (12/12/22). "Pressemitteilung: Minister Schulze übergibt Fördermittelbescheide für Neubauten". 2022-12-12
Genedata AG. (12/12/22). "Press Release: Icosagen Chooses Genedata Biologics to Digitalize Recombinant Antibody Discovery". Basel. 2022-12-12
Stadt Köln. (12/9/22). "Pressemitteilung: Rat gibt Mittel für Planung von Neubauten auf dem BioCampus Cologne frei". 2022-12-09
Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen. 2022-12-08
Max Planck Institute of Biochemsitry. (12/8/22). "Press Release: Karsten Borgwardt Becomes Director at the Max Planck Institute of Biochemistry". Martinsried. 2022-12-08
Ryvu Therapeutics S.A.. (12/8/22). "Press Release: Ryvu Therapeutics Initiates Public Offering of Shares [not for US, AU, CA, et al.]". Krakow. 2022-12-08
High-Tech Gründerfonds Management GmbH. (12/7/22). "Press Release: Variolytics Receives Seven-figure Seed Funding for Climate-neutral Wastewater Treatment Plants". Stuttgart. 2022-12-07
Merck KGaA. (12/6/22). "Press Release: Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition". Darmstadt. 2022-12-06
MorphoSys AG. (12/6/22). "Press Release: MorphoSys Out Licenses Pre-Clinical Oncology Program". Planegg. 2022-12-06
Bruker Corporation. (12/5/22). "Press Release: Bruker Completes the Acquisition of Neurescence Inc.". Billerica, MA. 2022-12-05
Fresenius Medical Care AG & Co. KGaA. (12/5/22). "Press Release: Helen Giza to Take Over as Chief Executive Officer of Fresenius Medical Care". 2022-12-05
faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim. 2022-11-30
BioNTech SE. (11/30/22). "Press Release: BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates". Mainz & Krakow. 2022-11-30
MiGenTra GmbH. (11/29/22). "Press Release: Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa". 2022-11-29
Cajal Neuroscience. (11/29/22). "Press Release: Cajal Neuroscience Launches with $96 Million to Transform Target and Drug Discovery in Neurodegeneration". Seattle, WA. 2022-11-29
Rgenta Therapeutics, Inc.. (11/29/22). "Press Release: Rgenta Therapeutics Raises $52M in Series A Financing". Cambridge, MA. 2022-11-29
Technische Universität München. (11/28/22). "Press Release: Nanoswitches for Tumor Targeting. TUM Spin-off Plectonic Develops Antibody-based Immunotherapies". 2022-11-28
Temedica GmbH. (11/23/22). "Press Release: Temedica Raises another €25 Million in Series B Funding to Expand Its Unique Real-world Insights Ecosystem". Munich. 2022-11-23
Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford. 2022-11-22
Catalym GmbH. (11/22/22). "Press Release: Catalym Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors". Oxford. 2022-11-22
Turbine Simulated Cell Technologies Ltd.. (11/22/22). "Press Release: Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform". London & Budapest. 2022-11-22
ObsEva S.A.. (11/22/22). "Press Release: ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million". Geneva. 2022-11-22
FogPharma (Fog Pharmaceuticals Inc.). (11/21/22). "Press Release: FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers". Cambridge, MA. 2022-11-21
Xlife Sciences AG. (11/21/22). "Press Release: Xlife Sciences Initiates a Review of Strategic Options". Zürich. 2022-11-21
European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". 2022-11-18
Cradle Bio B.V.. (11/17/22). "Press Release: Biotech Startup Cradle Exits Stealth, Raises $5.5M to Design Protein-machines and Cell-factories with AI". 2022-11-17
Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain. 2022-11-17
Sarcura GmbH. (11/17/22). "Press Release: Sarcura Secures € 7M Seed Plus Funding to Revolutionize Cell Therapy Manufacturing". Klosterneuburg. 2022-11-17
High-Tech Gründerfonds Management GmbH. (11/17/22). "Press Release: FundaMental Pharma Launches with EUR 10 Million in Seed Financing Led by BGV and Thuja Capital to Advance a First-in-Class Neuroprotectant". Heidelberg. 2022-11-17
Novigenix S.A.. (11/16/22). "Press Release: Novigenix Announces First Closing of Its $20M Series B". Lausanne. 2022-11-16
Rentschler Biopharma SE. (11/16/22). "Press Release: Rentschler Biopharma Appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board". Laupheim. 2022-11-16
Merck KGaA. (11/21622). "Press Release: Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity". Darmstadt. 2022-11-16
Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform". Boston, MA. 2022-11-15
Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases". Boston, MA. 2022-11-15
Bruker Corporation. (11/14/22). "Press Release: Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio". Billerica, MA. 2022-11-14
Air Liquide Healthcare. (11/14/22). "Press Release: Air Liquide Healthcare Federates Its Biobanking Activity under the Name BioKryo and Inaugurates Its New Site in Germany". Bagneux. 2022-11-14
BioNTech SE. (11/14/22). "Press Release: BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore". Mainz & Singapore. 2022-11-14
MorphoSys AG. (11/14/22). "Press Release: MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease". Planegg. 2022-11-14
Roche. (11/14/22). "Press Release: Roche Provides Update on Phase III GRADUATE Programme Evaluating Gantenerumab in Early Alzheimer’s Disease". Basel. 2022-11-14
Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen. 2022-11-11
Bayer AG. (11/10/22). "Press Release: Bayer Acquires German Biotech Start-up Targenomix". Monheim. 2022-11-10
Seagen Inc.. (11/10/22). "Press Release: Seagen Names David R. Epstein as Chief Executive Officer and Director". Bothell, WA. 2022-11-10
Atriva Therapeutics GmbH. (11/9/22). "Press Release: Atriva Therapeutics Appoints Christian Pangratz as Chief Executive Officer, Implementing Planned Management Change". Tübingen, Frankfurt a.M. & Martinsried. 2022-11-09
BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". 2022-11-08
Bruker Corporation. (11/8/22). "Press Release: Bruker Announces Acquisition of Inscopix for Neuroscience Research". Mountain View, CA. 2022-11-08
BioGeneration Ventures B.V.. (11/8/22). "Press Release: BGV Appoints Elena Ritsou as Venture Partner and Andree Blaukat as Senior Advisor". Amsterdam. 2022-11-08
Bruker Corporation. (11/7/22). "Press Release: Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference". Billerica, MA. 2022-11-07
Merck KGaA. (11/7/22). "Press Release: Merck Announces Collaboration with Biotheus to Accelerate Drug Submission and Approval Process for Biopharmaceutical Industry in China". Shanghai. 2022-11-07
Centogene N.V.. (11/3/22). "Press Release: Centogene Launches Rare and Neurodegenerative Disease Biodata Network". Cambridge, MA, Rostock & Berlin. 2022-11-03
Bayer AG. (11/3/22). "Press Release: Leaps by Bayer Leads Investment Round in AgTech Pioneer NuCicer to Bring Unique and Cost-effective Plant-protein Ingredients to Market by 2023". Davis, CA & Leverkusen. 2022-11-03
Exscientia plc. (11/3/22). "Press Release: Exscientia Expands Biologics Design Capability with Automated Laboratory". Oxford. 2022-11-03
Affimed N.V.. (11/3/22). "Press Release: Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101". Heidelberg & San Diego, CA. 2022-11-03
Alterome Therapeutics, Inc.. (11/2/22). "Press Release: Alterome Therapeutics Extends Series A to Nearly $100 Million to Advance Alteration-Specific Cancer Therapies". San Diego, CA. 2022-11-02
ADC Therapeutics S.A.. (11/1/22). "Press Release: ADC Therapeutics Appoints Kristen Harrington-Smith as Chief Commercial Officer and Peter Graham as Chief Legal Officer". Lausanne. 2022-11-01
ASC Oncology GmbH. (11/1/22). "Press Release: ASC Oncology Proudly Announces New Partnership with Tamer Group". Berlin. 2022-11-01
Memo Therapeutics AG. (11/1/22). "Press Release: Memo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology Targets". Schlieren. 2022-11-01
Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg. 2022-11-01
Evotec SE. (10/28/22). "Press Release: Evotec, CDP Venture Capital and Angelini Ventures Launch Translational Partnership »Extend« with Leading Italian Academic Institutions". Hamburg. 2022-10-28
MorphoSys AG. (10/27/22). "Press Release: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis". Planegg. 2022-10-27
Ariceum Therapeutics GmbH. (10/27/22). "Press Release: Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership". Berlin & North Augusta, SC. 2022-10-27
Kizoo Technology Capital GmbH. (10/26/22). "Press Release: Kizoo Invests in Rejuvenation Startup MoglingBio". Berlin & Ulm. 2022-10-26
Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise". 2022-10-26
ObsEva S.A.. (10/26/22). "Press Release: ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings". Geneva. 2022-10-26
Evotec SE. (10/25/22). "Press Release: Evotec Enters Partnership with Hannover Medical School to Create Molecular Patient Database in Autoimmune Diseases". Hamburg. 2022-10-25
Resolve Biosciences GmbH. (10/25/22). "Press Release: Resolve Biosciences Appoints Chief Commercial Officer to Drive Worldwide Adoption of Molecular Cartography Workflow". Monheim. 2022-10-25
Proteros Biostructures GmbH. (10/25/22). "Press Release: Proteros and Adrestia Initiate Multi-target Partnership to Discover First-in-class Drugs for Intractable Genetic Diseases". Martinsried. 2022-10-25
Alto Neuroscience Inc.. (10/25/22). "Press Release: Alto Neuroscience Announces $35 Million Series B Financing". Los Altos, CA. 2022-10-25
Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim. 2022-10-24
Hookipa Pharma Inc.. (10/20/22). "Press Release: Hookipa Announces Strategic Collaboration and License Agreement with Roche to Develop Novel Arenaviral Immunotherapy for KRAS-mutated Cancers". New York, NY & Vienna. 2022-10-20
Boehringer Ingelheim. (10/20/22). "Press Release: University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs". Tübingen & Ingelheim. 2022-10-20
HMNC Holding GmbH. (10/20/22). "Press Release: HMNC Brain Health Raises EUR 14.3 million to Advance Precision Psychiatry Therapies". Munich. 2022-10-20
FyoniBio GmbH. (10/20/22). "Press Release: FyoniBio and Strike Pharma Sign a Master Service Agreement Covering Cell Line Development for a Novel Bi-specific Therapeutic mAb". Berlin & Stockholm. 2022-10-20
Nucleome Therapeutics Ltd.. (10/19/22). "Press Release: Nucleome Therapeutics Raises oversubscribed £37.5 Million Series A Financing to Decode the Dark Matter of the Human Genome and Deliver First-in-Class Precision Medicines". Oxford. 2022-10-19
Celeris Therapeutics GmbH. (10/19/22). "Press Release: Celeris Therapeutics to Receive 12.5 Million Euros in Funding from the European Innovation Council". Graz. 2022-10-19
Empyrean Neuroscience, Inc.. (10/18/22). "Press Release: Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders". New York, NY & Cambridge. 2022-10-18
Anokion S.A.. (10/18/22). "Press Release: Anokion Announces $35 Million Equity Investment from Pfizer". Cambridge, MA & Lausanne. 2022-10-18
Co.don AG. (10/17/22). "Pressemitteilung: Vereinbarung über die Veräußerung des Geschäftsbetriebs". Teltow & Leipzig. 2022-10-17
Wacker Chemie AG. (10/12/22). "Press Release: Neuway Pharma and Wacker Launch Research Project to Develop RNA-Based Actives for the Treatment of Central Nervous System Diseases". Munich & Bonn. 2022-10-12
BioM Biotech Cluster Development GmbH. (10/12/22). "Press Release: Osaka and Munich Continue Their Cuccessful Partnership". 2022-10-12
Apollo Health Ventures. (10/11/22). "Press Release: Apollo Health Ventures and Paul Scherrer Institute Launch Focal Biosciences". Boston, MA, Berlin & Villigen. 2022-10-11
faCelliate GmbH. (10/11/22). "Press Release: faCellitate Starts Marketing New 384-well Spheroid Microplate". Mannheim. 2022-10-11
Immatics N.V.. (10/10/22). "Press Release: Immatics Announces $110 Million Underwritten Offering of Ordinary Shares". Houston, TX & Tübingen. 2022-10-10
Immatics N.V.. (10/10/22). "Press Release: Immatics Reports Interim Clinical Data Update on ACTengine IMA203 TCR-T Monotherapy Targeting PRAME". Houston, TX & Tübingen. 2022-10-10
Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. 2022-10-10
next pagenext page 1 2 3 ... 8 9 10 ... 35 36 37  next pagenext page


Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group World of Partnering Opportunities 650x300px

» top